Humana Inc. (HUM) News
Filter HUM News Items
HUM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HUM News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest HUM News From Around the Web
Below are the latest news stories about HUMANA INC that investors may wish to consider to help them evaluate HUM as an investment opportunity.
3 HMO Stocks Poised to Thrive Despite Industry HeadwindsThe Medical-HMO industry benefits from a growing customer base and contract wins. However, industry challenges like rising costs and workforce shortages remain a concern. UNH, HUM and CNC are likely to navigate industry storms. |
Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025LOUISVILLE, Ky., January 09, 2025--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2024 (4Q24), as well as prepared management remarks (in PDF format), on Tuesday, February 11, 2025, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. |
Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality IndexLOUISVILLE, Ky., January 07, 2025--Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index |
Humana price target raised to $290 from $260 at TruistTruist raised the firm’s price target on Humana (HUM) to $290 from $260 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is key and ca |
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?Improving the consumer experience, engagement and trust is emerging as a top strategy for healthcare companies. |
How Health Insurers Racked Up Billions in Extra Payments From Medicare AdvantageThe Wall Street Journal’s yearlong investigation into Medicare’s private insurers relied on exclusive access to billions of records of Medicare services. |
Is Humana Inc. (HUM) the Best Pharma Dividend Stock to Buy In 2024?We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […] |
Humana (NYSE:HUM) Seems To Use Debt Quite SensiblyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the... |
UnitedHealth’s Army of Doctors Helped It Collect Billions More From MedicareThe biggest Medicare Advantage insurer presented physicians with checklists of potential diagnose.; “I didn’t think I was obese,” one suspicious patient told his doctor. |
Is Humana Inc.'s (NYSE:HUM) Recent Price Movement Underpinned By Its Weak Fundamentals?Humana (NYSE:HUM) has had a rough three months with its share price down 18%. It seems that the market might have... |